Gevo, Inc. GEVO
Nasdaq · XNAS · stock · Industrial Organic Chemicals
Chart by TradingView
3/9
Piotroski F — financial health
-1.4
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2025 | $160.6M | -$33.8M | — | -$43.5M | $466.3M |
| 2024 | $16.9M | -$78.6M | — | -$108.5M | $489.5M |
| 2023 | $17.2M | -$66.2M | — | -$108.2M | $557.4M |
| 2022 | $1.2M | -$98.0M | — | -$128.4M | $605.5M |
| 2021 | $533,000 | -$59.2M | -$11.5M | -$105.0M | $547.3M |
| 2020 | $5.5M | -$40.2M | -$9.5M | -$25.6M | $146.4M |
Recent insider activity (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| Gruber Patrick R. | director | 2026-06-12 | Sell | 157,563 | $1.40 |
| Agiri Oluwagbemileke Yusuf | CFO | 2026-06-12 | Sell | 63,028 | $1.40 |
| Bowron Kimberly T | Chief of Staff | 2026-06-12 | Sell | 15,470 | $1.43 |
| Gendenjamts Davaajargal | VP Acctg and Treasurer | 2026-06-12 | Sell | 4,293 | $1.43 |
| Shafer Andrew | Chief Mktg Cust & Brnd Officer | 2026-06-12 | Sell | 9,443 | $1.43 |
| Ryan Christopher Michael | President & COO | 2026-06-12 | Sell | 35,196 | $1.43 |
| Bloom Paul D | CEO | 2026-06-12 | Sell | 35,189 | $1.43 |
| Mize Gary W. | director | 2026-05-27 | Grant | 70,000 | — |
Why these scores methodology →
Piotroski F-score: 3/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -1.4 (distress)
- Working capital / assets 0.09
- Retained earnings / assets -1.16
- EBIT / assets -0.028
- Equity / liabilities 1.882
Source: SEC EDGAR filings · CIK 0001392380 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.